Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2012
10/04/2012US20120251581 Novel Compound and Methods for its Production
10/04/2012US20120251578 Diagnostic, Therapeutic And A Vaccine Against Treponemes
10/04/2012US20120251577 Selectively disrupted whole-cell vaccine
10/04/2012US20120251571 Rnase l-mediated cleavage products and uses thereof
10/04/2012US20120251570 Method, kit, plasmid and composition for inducing an immune response to dengue virus, on the basis of dna and chimeric virus vaccines
10/04/2012US20120251569 Composition for treating hbv infection
10/04/2012US20120251568 Recombinant influenza viruses and uses thereof
10/04/2012US20120251565 Compositions and methods for preventing or treating burkholderia infection
10/04/2012US20120251564 Reovirus compositions and methods of use
10/04/2012US20120251563 Modulation of immune response by non-peptide binding stress response polypeptides
10/04/2012US20120251562 Inhibitors of the PP1/GADD34 Complex for the Treatment of a Condition Requiring an Immunosuppressive Activity
10/04/2012US20120251550 Crystalline anti-hTNFalpha antibodies
10/04/2012US20120251547 Il-17 receptor a antigen binding proteins
10/04/2012US20120251542 Anti-toxin vaccine compositions and methods of use thereof
10/04/2012US20120251540 Stabilized single domain antibodies
10/04/2012US20120251537 Compositions and methods for the treatment of infections and tumors
10/04/2012US20120251533 Monoclonal antibodies against cd30 lacking in fucosyl residues
10/04/2012US20120251527 Podocyte specific assays and uses thereof
10/04/2012US20120251525 Method of utilizing azelaic acid esters to modulate communications mediated by biological molecules
10/04/2012US20120251521 Technical field and industrial applicability of the invention
10/04/2012US20120251505 HUMAN LYMPHOID TISSUE INDUCER (LTi) CELL COMPOSITIONS AND METHODS OF USE
10/04/2012US20120251497 Inhibitors of hepatitis c virus
10/04/2012US20120251495 Pterin based therapies for inflammatory conditions
10/04/2012US20120251493 Novel macrocyclic inhibitors of hepatitis c virus replication
10/04/2012US20120251492 Triterpene derivative and agent for preventing or treating chronic hepatitis c
10/04/2012US20120251491 Fused tricyclic aryl compounds useful for the treatment of viral diseases
10/04/2012US20120251487 Compounds and pharmaceutical compositions for the treatment of viral infections
10/04/2012US20120251467 Fulvic acid compositions and their use
10/04/2012US20120251464 Chalcones as enhancer of antimicrobial agents
10/04/2012US20120251454 Human Anti-IL-23 Antibodies, Compositions, Methods and Uses
10/04/2012US20120251444 Treatment of liver disorders by administration of rap conjugates
10/04/2012US20120247462 Antibiotic formulations, unit doses, kits, and methods
10/04/2012CA2831799A1 Novel oxazolidinone derivative and pharmaceutical composition including the same
10/04/2012CA2831675A1 Treatment for infection with hepatitis b virus alone or in combination with hepatitis delta virus and associated liver diseases
10/04/2012CA2831428A1 Alisporivir to treat hepatitis c virus infection
10/04/2012CA2831421A1 Novel cephalosporin derivatives and pharmaceutical compositions thereof
10/04/2012CA2831294A1 Compositions and methods to immunize against hepatitis c virus
10/04/2012CA2830831A1 Macrocyclic compounds and methods for their production
10/04/2012CA2830827A1 Macrocyclic compound and methods for its production
10/04/2012CA2830806A1 Stable formulations of antibodies to human programmed death receptor pd-1 and related treatments
10/04/2012CA2830305A1 Non-pathogenic serotype 4 fowl adenovirus (fadv-4) and viral vector thereof
10/04/2012CA2830112A1 Selection of hcv treatment
10/04/2012CA2828423A1 3-ureidoisoquinolin-8-yl derivatives
10/04/2012CA2827214A1 Lipoxygenase inhibitors
10/03/2012EP2505210A1 Conjugated molecules comprising a peptide derived from the CD4 receptor coupled to a polyanionic polypeptide for the treatment of aids
10/03/2012EP2505203A2 Antiviral composition containing an aleurites fordii or daphne kiusiana extract or a fraction thereof as an active ingredient
10/03/2012EP2504353A2 Lipopeptide compositions and related methods
10/03/2012EP2504344A1 Hepatitis c inhibitor compounds
10/03/2012EP2504343A1 Hepatitis c inhibitor compounds
10/03/2012EP2504326A1 Sialochimeric compounds
10/03/2012EP2504064A2 Biofilm disruptive compositions
10/03/2012EP2504016A1 Inhibition of pancreatic lipase
10/03/2012EP2503881A1 Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases
10/03/2012CN202459409U Biofibre facial mask containing nano silver
10/03/2012CN1894281B Treatment of viral infections
10/03/2012CN1695638B Probiotic therapy of neonatal meningitis and method of using e. coli virulence determinatns
10/03/2012CN102712931A Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom
10/03/2012CN102712908A Recombinant measles virus useful as bivalent vaccine against measles and nipah virus infection
10/03/2012CN102712907A Recombinant measles virus useful as bivalent vaccine against measles and malaria infection
10/03/2012CN102712680A Modified steptococcus pneumonia pneumolysin (PLY) polypeptides
10/03/2012CN102712677A Lipopeptide compositions and related methods
10/03/2012CN102712657A Antimicrobial compounds and methods of making and using the same
10/03/2012CN102712647A Antimicrobial compounds and methods of making and using the same
10/03/2012CN102712644A Novel macrocyclic inhibitors of hepatitis C virus replication
10/03/2012CN102712641A MK2 inhibitors
10/03/2012CN102712633A Inhibitors of flaviviridae viruses
10/03/2012CN102712632A Inhibitors of flaviviridae viruses
10/03/2012CN102712623A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
10/03/2012CN102712597A Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents
10/03/2012CN102712596A New secondary 8-hydroxyquinoline-7-carboxamide derivatives
10/03/2012CN102711817A Method, kit, plasmid and composition for inducing an immune response to dengue virus, on the basis of DNA and chimeric virus vaccines
10/03/2012CN102711815A Adjuvant for vaccines, vaccines that comprise said adjuvant and uses thereof
10/03/2012CN102711787A PAR1 antagonists for use in the treatment or prevention of influenza virus type A infections
10/03/2012CN102711781A A novel boswellia low polar gum resin extract and its synergistic compositions
10/03/2012CN102711765A Kinase inhibitors
10/03/2012CN102711747A Method for treating herpes virus infection
10/03/2012CN102711745A Topical use of hydroxytyrosol and derivatives for the prevention of HIV infection
10/03/2012CN102711709A Devices, methods, and composition for controlling infections
10/03/2012CN102703505A Co-expressed brucella recombinant adenovirus as well as preparation method and use thererof
10/03/2012CN102703491A Bacteria-cracking preparation for effectively cracking escherichia coli as well as cracking method and application thereof
10/03/2012CN102703472A Pathogenesis-related protein gene of hulless oat and protein encoded by pathogenesis-related protein gene
10/03/2012CN102703457A Method for preparing and expressing antibacterial peptide gene
10/03/2012CN102703393A Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
10/03/2012CN102703390A Grass carp hemorrhage antigenic protein, preparation method and application thereof
10/03/2012CN102703369A Recombinant bifidobacterium for preparing EV (Enterovirus) 71 vaccine as well as preparation method and application of recombinant bifidobacterium
10/03/2012CN102703365A Bacillus subtilis with bacteriostatic activity
10/03/2012CN102702833A Anion powder
10/03/2012CN102702451A High-efficiency and antibacterial polymeric micelle with high pH sensibility and biocompatibility and preparation method thereof
10/03/2012CN102702376A Process for extracting chestnut polysaccharide by pressurized solvent extraction method
10/03/2012CN102702352A Human anti-EV71 virus neutralization antibody EV71FabL4 and preparation method and application thereof
10/03/2012CN102702351A Humanized EV71 antivirus neutralizing antibody EV71FabL6 and preparation method and application thereof
10/03/2012CN102702348A Monoclonal antibodies against Enterovirus 71 and uses thereof
10/03/2012CN102702333A Drug-resistant pathogen infection resistant polypeptide and uses thereof
10/03/2012CN102702288A Method for glycosylation of flavonoid compounds
10/03/2012CN102702277A Compound of single sugar cluster and heterozygous sugar cluster, preparation method and applications thereof
10/03/2012CN102702260A Methods of reducing nephrotoxicity in subjects administered with nucleoside
10/03/2012CN102702210A Application of phthalocyanine metal complex containing piperazine ethyoxyl modified groups
10/03/2012CN102702194A Anti-viral compounds
10/03/2012CN102702193A Anti-viral compounds
10/03/2012CN102702184A Novel oxazolidinone derivatives
1 ... 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 ... 1798